SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019437
Filing Date
2018-08-06
Accepted
2018-08-06 16:16:53
Documents
43
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kura-10q_20180630.htm 10-Q 1612821
2 EX-10.5 kura-ex105_43.htm EX-10.5 81035
3 EX-31.1 kura-ex311_7.htm EX-31.1 17366
4 EX-32.1 kura-ex321_6.htm EX-32.1 8652
  Complete submission text file 0001564590-18-019437.txt   5100502

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT kura-20180630.xml EX-101.INS 1224001
6 XBRL TAXONOMY EXTENSION SCHEMA kura-20180630.xsd EX-101.SCH 31118
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20180630_cal.xml EX-101.CAL 33910
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20180630_def.xml EX-101.DEF 75201
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20180630_lab.xml EX-101.LAB 210761
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20180630_pre.xml EX-101.PRE 151687
Mailing Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121
Business Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 18994944
SIC: 2834 Pharmaceutical Preparations